Related references
Note: Only part of the references are listed.Serum cell-free DNA methylation of OPCML and HOXD9 as a biomarker that may aid in differential diagnosis between cholangiocarcinoma and other biliary diseases
Wiphawan Wasenang et al.
CLINICAL EPIGENETICS (2019)
Gastric Adenocarcinoma Associated with Acute Endocarditis of the Aortic Valve and Coronary Artery Disease in a 61-Year-Old Male with Multiple Comorbidities-Combined Surgical Management-Case Report
Horatiu Moldovan et al.
MEDICINA-LITHUANIA (2019)
The Airway Transcriptome as a Biomarker for Early Lung Cancer Detection
Ehab Billatos et al.
CLINICAL CANCER RESEARCH (2018)
Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations
Christopher P. Wardell et al.
JOURNAL OF HEPATOLOGY (2018)
Proteomics detection of S100A6 in tumor tissue interstitial fluid and evaluation of its potential as a biomarker of cholangiocarcinoma
Sudarat Onsurathum et al.
TUMOR BIOLOGY (2018)
Differential Integration of Transcriptome and Proteome Identifies Pan-Cancer Prognostic Biomarkers
Gregory W. Schwartz et al.
FRONTIERS IN GENETICS (2018)
Methylated promoter DNA of CDO1 gene and preoperative serum CA19-9 are prognostic biomarkers in primary extrahepatic cholangiocarcinoma
Shuji Nakamoto et al.
PLOS ONE (2018)
A comparative proteomic analysis of bile for biomarkers of cholangiocarcinoma
Marut Laohaviroj et al.
TUMOR BIOLOGY (2017)
Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma
Apinya Jusakul et al.
CANCER DISCOVERY (2017)
Plasma orosomucoid 2 as a potential risk marker of cholangiocarcinoma
Rucksak Rucksaken et al.
CANCER BIOMARKERS (2017)
Translating Cancer Genomes and Transcriptomes for Precision Oncology
Sameek Roychowdhury et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Upregulation of 14-3-3 eta in chronic liver fluke infection is a potential diagnostic marker of cholangiocarcinoma
Ornuma Haonon et al.
PROTEOMICS CLINICAL APPLICATIONS (2016)
Epigenetics, cellular memory and gene regulation
Steven Henikoff et al.
CURRENT BIOLOGY (2016)
A Hippo and Fibroblast Growth Factor Receptor Autocrine Pathway in Cholangiocarcinoma
Sumera Rizvi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Promoter hypermethylation of SHOX2 and SEPT9 is a potential biomarker for minimally invasive diagnosis in adenocarcinomas of the biliary tract
V. Branchi et al.
CLINICAL EPIGENETICS (2016)
Pathogenesis of cholangiocarcinoma: From genetics to signalling pathways
Sarinya Kongpetch et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2015)
Genetics of Opisthorchis viverrini-related cholangiocarcinoma
Apinya Jusakul et al.
CURRENT OPINION IN GASTROENTEROLOGY (2015)
Four DNA Methylation Biomarkers in Biliary Brush Samples Accurately Identify the Presence of Cholangiocarcinoma
Kim Andresen et al.
HEPATOLOGY (2015)
HER2/neu-directed therapy for biliary tract cancer
Milind Javle et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2015)
DNA methylation level of OPCML and SFRP1: a potential diagnostic biomarker of cholangiocarcinoma
Rattaya Amornpisutt et al.
TUMOR BIOLOGY (2015)
An Omics Perspective on Molecular Biomarkers for Diagnosis, Prognosis, and Therapeutics of Cholangiocarcinoma
Pattaya Seeree et al.
INTERNATIONAL JOURNAL OF GENOMICS (2015)
The novel colorectal cancer biomarkers CDO1, ZSCAN18 and ZNF331 are frequently methylated across gastrointestinal cancers
Hege Marie Vedeld et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Global Alterations of DNA Methylation in Cholangiocarcinoma Target the Wnt Signaling Pathway
Benjamin Goeppert et al.
HEPATOLOGY (2014)
Increase of exostosin 1 in plasma as a potential biomarker for opisthorchiasis-associated cholangiocarcinoma
Jarinya Khoontawad et al.
TUMOR BIOLOGY (2014)
Mutational landscape of intrahepatic cholangiocarcinoma
Shanshan Zou et al.
NATURE COMMUNICATIONS (2014)
Differential Expression of Fascin, E-cadherin and Vimentin: Proteins Associated With Survival of Cholangiocarcinoma Patients
Xianhai Mao et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2013)
The Long Journey of Cancer Biomarkers from the Bench to the Clinic
Maria P. Pavlou et al.
CLINICAL CHEMISTRY (2013)
Genomic Decoding of Intrahepatic Cholangiocarcinoma Reveals Therapeutic Opportunities
Jesper B. Andersen et al.
GASTROENTEROLOGY (2013)
Integrative Molecular Analysis of Intrahepatic Cholangiocarcinoma Reveals 2 Classes That Have Different Outcomes
Daniela Sia et al.
GASTROENTEROLOGY (2013)
A Prospective Proteomic-Based Study for Identifying Potential Biomarkers for the Diagnosis of Cholangiocarcinoma
Yuan Shi et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2013)
Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers
Waraporn Chan-on et al.
NATURE GENETICS (2013)
Annexin A1: A new immunohistological marker of cholangiocarcinoma
Nuttanan Hongsrichan et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Proteomic analysis to identify plasma orosomucoid 2 and kinesin 18A as potential biomarkers of cholangiocarcinoma
Rucksak Rucksaken et al.
CANCER BIOMARKERS (2012)
被撤回的出版物: Proteomics-based identification of α-enolase as a potential prognostic marker in cholangiocarcinoma (Retracted article. See vol. 49, pg. 196, 2016)
Ponlapat Yonglitthipagon et al.
CLINICAL BIOCHEMISTRY (2012)
Novel target genes and a valid biomarker panel identified for cholangiocarcinoma
Kim Andresen et al.
EPIGENETICS (2012)
Serum α1β-glycoprotein and afamin ratio as potential diagnostic and prognostic markers in cholangiocarcinoma
Arthit Tolek et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2012)
IDH mutations: new genetic signatures in cholangiocarcinoma and therapeutic implications
Darrell R. Borger et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2012)
Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update
Shahid A. Khan et al.
GUT (2012)
Prognostic significance of peroxiredoxin 1 and ezrin-radixin-moesin binding phosphoprotein 50 in cholangiocarcinoma
Ponlapat Yonglitthipagon et al.
HUMAN PATHOLOGY (2012)
Bile-Based Detection of Extrahepatic Cholangiocarcinoma with Quantitative DNA Methylation Markers and Its High Sensitivity
So-Hyun Shin et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2012)
Exome sequencing of liver fluke-associated cholangiocarcinoma
Choon Kiat Ong et al.
NATURE GENETICS (2012)
Comparative Proteomic Profiling of Human Bile Reveals SSP411 as a Novel Biomarker of Cholangiocarcinoma
Jian Shen et al.
PLOS ONE (2012)
CpG-island methylation study of liver fluke-related cholangiocarcinoma
R. Sriraksa et al.
BRITISH JOURNAL OF CANCER (2011)
DNA Methylation: A Timeline of Methods and Applications
Alan Harrison et al.
Frontiers in Genetics (2011)
Proteomic Analysis of Differentially Expressed Proteins in Peripheral Cholangiocarcinoma
Ian A. Darby et al.
CANCER MICROENVIRONMENT (2011)
Preclinical Assessment of Simultaneous Targeting of Epidermal Growth Factor Receptor (ERBB1) and ERBB2 as a Strategy for Cholangiocarcinoma Therapy
Zichen Zhang et al.
HEPATOLOGY (2010)
Up-regulation of annexin A2 in cholangiocarcinoma caused by Opisthorchis viverrini and its implication as a prognostic marker
Ponlapat Yonglitthipagon et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2010)
A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer
Ramesh K. Ramanathan et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Characterization of apolipoprotein A-I as a potential biomarker for cholangiocarcinoma
X. Wang et al.
EUROPEAN JOURNAL OF CANCER CARE (2009)
Preferentially different mechanisms of inactivation of 9p21 gene cluster in liver fluke-related cholangiocarcinoma
Patcharee Chinnasri et al.
HUMAN PATHOLOGY (2009)
Fascin overexpression is involved in carcinogenesis and prognosis of human intrahepatic cholangiocarcinoma: immunohistochemical and molecular analysis
Tomohiro Iguchi et al.
HUMAN PATHOLOGY (2009)
Fascin is involved in tumor necrosis factor-α-dependent production of MMP9 in cholangiocarcinoma
Manabu Onodera et al.
LABORATORY INVESTIGATION (2009)
Cholangiocarcinoma: lessons from Thailand
Banchob Sripa et al.
CURRENT OPINION IN GASTROENTEROLOGY (2008)
Decreased expression of galectin-3 is associated with metastatic potential of liver fluke-associated cholangiocarcinoma
Mutita Junking et al.
EUROPEAN JOURNAL OF CANCER (2008)
Serum levels of variants of transthyretin down-regulation in cholangiocarcinoma
Liyun Liu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Liver fluke induces cholangiocarcinoma
Banchob Sripa et al.
PLOS MEDICINE (2007)
Comparison of gene expression profiles between Opisthorchis viverrini and non-Opisthorchis viverrini associated human intrahepatic cholangiocarcinoma
Natini Jinawath et al.
HEPATOLOGY (2006)
Cholangiocarcinoma
T Patel
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2006)
Genome-wide analysis of gene expression in human intrahepatic cholangiocarcinoma
K Obama et al.
HEPATOLOGY (2005)
Promoter hypermethylation is a major event of hMLH1 gene inactivation in liver fluke related cholangiocarcinoma
T Limpaiboon et al.
CANCER LETTERS (2005)
A proteomic analysis of human bile
TZ Kristiansen et al.
MOLECULAR & CELLULAR PROTEOMICS (2004)
Mac-2-binding protein is a diagnostic marker for biliary tract carcinoma
J Koopmann et al.
CANCER (2004)
Expression of endogenous Galectin-1 and Galectin-3 in intrahepatic cholangiocarcinoma
T Shimonishi et al.
HUMAN PATHOLOGY (2001)
Share Paper
